基于网络药理学预测银杏蜜环口服溶液治疗冠心病与焦虑症的分子机制

关双; 苏苑苑; 刘琼; 李兵; 顾浩; 魏鹏璐; 刘骏; 王忠

doi:10.13422/j.cnki.syfjx.20181535

您当前的位置：

首页 >

文章列表页 >

基于网络药理学预测银杏蜜环口服溶液治疗冠心病与焦虑症的分子机制

数据挖掘 | 更新时间：2024-01-04

- 基于网络药理学预测银杏蜜环口服溶液治疗冠心病与焦虑症的分子机制
- Molecular Mechanisms of Yinxing Mihuan Oral Solution on Coronary Heart Disease and Anxiety Disorder Based on Network Pharmacology
- 中国实验方剂学杂志 2018年24卷第15期页码：182-189
- 作者机构：
- 作者简介：
- 基金信息：
  
  国家“重大新药创制”科技重大专项（2017ZX09301059）
- DOI：10.13422/j.cnki.syfjx.20181535
  中图分类号： R259
- 纸质出版日期：2018
- 稿件说明：
移动端阅览
关双, 苏苑苑, 刘琼, 等. 基于网络药理学预测银杏蜜环口服溶液治疗冠心病与焦虑症的分子机制[J]. 中国实验方剂学杂志, 2018,24(15):182-189.

GUAN Shuang, SU Yuan-yuan, LIU Qiong, et al. Molecular Mechanisms of Yinxing Mihuan Oral Solution on Coronary Heart Disease and Anxiety Disorder Based on Network Pharmacology[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(15): 182-189.
关双, 苏苑苑, 刘琼, 等. 基于网络药理学预测银杏蜜环口服溶液治疗冠心病与焦虑症的分子机制[J]. 中国实验方剂学杂志, 2018,24(15):182-189. DOI： 10.13422/j.cnki.syfjx.20181535.

GUAN Shuang, SU Yuan-yuan, LIU Qiong, et al. Molecular Mechanisms of Yinxing Mihuan Oral Solution on Coronary Heart Disease and Anxiety Disorder Based on Network Pharmacology[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(15): 182-189. DOI： 10.13422/j.cnki.syfjx.20181535.

摘要

目的：对银杏蜜环口服溶液进行网络药理学研究，探究其治疗冠心病与焦虑症的分子作用机制。方法：通过比较毒理基因组学数据库（Comparative Toxicogenomics Database，CTD）数据库获得银杏蜜环口服溶液有效成分和通过人类表型本体（HPO）数据库和Disease Connect数据库获得冠心病、焦虑症的靶点基因，运用STRING数据库，构建银杏蜜环口服溶液有效成分和冠心病，焦虑症的靶点基因网络。通过DAVID数据库综合比较分析，获得银杏蜜环口服溶液治疗冠心病，焦虑症的靶点基因的基因本体（Gene_Ontology，GO）功能和生物学通路。结果：银杏蜜环口服溶液的靶点基因网络有磷酸酶与张力蛋白同源物（PTEN），白细胞介素-10（IL-10），Smad3等32个基因，557个GO功能如生物质量调控、脂质稳态、睡眠的恒定机制等，20条京都基因组百科全书（Kyoto Encyclopedia of Genes and Genomes，KEGG）与冠心病重叠；有死骨片蛋白1（SQSTM1），超氧化物歧化酶1（SOD1），对氧磷酶1（PON1）等16个基因，260个GO功能如发育过程、细胞成分组织、声音的感官知觉等，10条KEGG通路与焦虑症重叠。经文献验证有10条通路和冠心病相关，4条通路与焦虑症有关。结论：银杏蜜环口服溶液可能通过干预MAPK信号通路同时对冠心病和焦虑症起到治疗效果。

Abstract

Objective: To reveal the molecular mechanism of Yinxing Mihuan oral solution for coronary heart disease and anxiety. Method: The effective ingredients in Yinxing Mihuan oral solution were obtained from Comparative Toxicogenomics Database (CTD)

and thetarget genes of coronary heart disease and anxiety were obtained from Human Phenotype Ontology(HPO) and Disease Connect.STRING database was used to build thetarget gene networks of the effective components in Yinxing Mihuan oral solution and coronary heart disease and anxiety. The Gene_Ontology(GO)biological process functions and targeted Kyoto Encyclopedia of Genes and Genomes(KEGG)pathways of the gene networks of the drug and the two diseases were compared by DAVID bioinformatic software 6.7. Result: The target gene network of Yinxing Mihuan oral solution had 32 genes

such as phos-phatase and tensin homolog(PTEN)

interleukin(IL)-10

Smad3

557 GO functions

such asregulation of biological

qualitylipid homeostasis and homeostatic process; 20 KEGG pathways were overlapped with coronary heart disease; 16 genes

such as sequestosome 1(SQSTM1)

super oxide dismutase(SOD1)

paraoxyphosphatase 1(PON1)

260 GO functions

such as developmental process

cellular component organization

sensory perception of sound

and 10 KEGG pathways were overlapped with anxiety disorders.Literatures verified that 10 pathways were associated with coronary heart disease and 4 pathways were associated with anxiety. Conclusion: Yinxing Mihuan oral solution may play a therapeutic effect on coronary heart disease and anxiety by intervening MAPK signaling pathway.

关键词

Keywords

references

浏览量

507

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

复方狼毒酊干预湿毒蕴结型多发性掌跖疣的临床疗效及机制探讨

治疗慢性萎缩性胃炎新方的挖掘及其对胃阴亏虚证型的验证

基于cAMP通路探究功劳木生物碱调节突触可塑性改善抑郁症的作用机制

保心颗粒调控铁死亡治疗心力衰竭的潜在活性成分及分子机制分析

基于代谢组学的痰瘀阻络证心肌缺血再灌注损伤大鼠模型的建立及评价